IM Cannabis Corp. Faces Nasdaq Compliance Challenge and Plans Acquisition

IM Cannabis Corp ( (TSE:IMCC) ) has provided an update.

On April 11, 2025, IM Cannabis Corp. received a notification from Nasdaq indicating non-compliance with listing requirements due to insufficient stockholders’ equity. The company has until May 26, 2025, to submit a compliance plan to Nasdaq, which could extend the deadline for compliance by up to 180 days. Meanwhile, IM Cannabis Corp. plans to acquire the remaining 26% of Focus Medical Herbs Ltd. from Ewave Group Ltd., with the transaction subject to shareholder approval at an upcoming meeting on May 23, 2025. This acquisition aims to consolidate the company’s interests in Focus, enhancing its market positioning and operational capabilities.

Spark’s Take on TSE:IMCC Stock

According to Spark, TipRanks’ AI Analyst, TSE:IMCC is a Neutral.

IM Cannabis Corp’s overall score reflects its financial struggles, particularly in profitability and liquidity, despite some positive developments in operational cost management and market expansion in Germany. The negative financial metrics and valuation concerns weigh heavily on its score, though recent improvements in earnings provide some optimism for future performance.

To see Spark’s full report on TSE:IMCC stock, click here.

More about IM Cannabis Corp

IM Cannabis Corp. operates in the cannabis industry, focusing on the cultivation, production, and distribution of medical cannabis. The company is actively involved in the Israeli and German markets, with a strategic emphasis on expanding its presence in the medical cannabis distribution and retail segments.

YTD Price Performance: -24.12%

Average Trading Volume: 8,902

Technical Sentiment Signal: Buy

Current Market Cap: $5.27M

Learn more about IMCC stock on TipRanks’ Stock Analysis page.